Class / Patent application number | Description | Number of patent applications / Date published |
604502000 | Therapeutic material introduced by subcutaneous implant (e.g., peritoneal injectors) | 16 |
20080306466 | Implantable Infusion Devices Including Apparatus For Confirming Side Port Access - Implantable infusion devices and systems with side port access detection capability and methods of detecting side port access. | 12-11-2008 |
20090043276 | DRUG DELIVERY DEVICE, COMPOSITIONS AND METHODS RELATING THERETO - An implantable drug delivery device including at least one flexible elongate element, the flexible elongate element including a polymeric carrier for a drug and anchors for attachment to a vessel wall of the patient. | 02-12-2009 |
20090043277 | Treatment for patients after removal of saphenous vascular material - A device and method for using the device is used for clotting volumes created postoperatively. The device is inserted into a cavity formed by removal of tissue or organ within a patient. The device may have a flexible tubing having a surface material; a blood clotting material enclosed within the surface material of the tubing; a guidewire associated with the device that when placed under tension, stabilizes the tubing radially or longitudinally; and the surface material of the tubing being removable from the enclosed blood clotting material while the guidewire is under tension. | 02-12-2009 |
20090198210 | DEVICE FOR INTERMITTENTLY OBSTRUCTING A GASTRIC OPENING AND METHOD OF USE - The present invention relates to a device for intermittently obstructing a bodily opening, such as a gastric opening, and includes a proximal member connected to a distal member by a tether. The proximal member includes an apron member surrounding a first occluding member, which is formable from an elongated and narrower configuration to a contracted or expanded but wider configuration. When employed in the stomach, the device of the present invention is arranged transluminally, with the distal member disposed in the duodenum and the proximal member disposed against the pyloric valve, intermittently occluding the pyloric valve and preventing or delaying the flow of gastric contents through the pyloric valve. In certain embodiments, a reservoir may be included for releasing a substance of interest, for example for releasing insulin from a reservoir disposed in the distal member. Sensors, actuators, and data transmission devices may also be included. | 08-06-2009 |
20090247983 | Method and System for Sustained-Release of Sclerosing Agent - Methods and systems for treating pleural disease comprising a providing a low dosage of a sclerosing agent over a period of time. Certain examples include catheter with a sclerosing agent that is inserted into the pleural space. The sclerosing agent is released in a sustained-release manner over a period of time to achieve diffuse pleurodesis of the pleural layers. | 10-01-2009 |
20100049163 | Drug delivery device, kit and method for peroperative local pharmacological treatment of bone surfaces - A drug delivery device for local administration of a solution or suspension of a drug, such as a bone modulating drug, to a bone surface, comprising a ductile, absorbent material comprising said drug and being of a shape adapted or adaptable to the bone surface. The drug delivery device may additionally comprise a support of a non-absorbent material and a handle piece. The bone modulating drug may be chosen from bisphosphonates, statins, growth factors, signaling proteins and bone morphogenic protein. The device may be used in peroperatively treating a bone surface by local administration to the surface of the drug. | 02-25-2010 |
20100057039 | DEVICES AND SYSTEMS FOR LOCAL DELIVERY OF INOTROPIC AGENTS TO THE EPICARDIUM - Devices and methods are provided for delivery of a positive inotropic agent to the heart of a patient in need thereof. An epicardial patch includes (i) a backing layer which is impermeable to the positive inotropic agent; and (ii) a drug release layer attached to the backing layer and including the positive inotropic agent and a polymeric membrane material. The polymeric membrane material provides controlled release of the positive inotropic agent to the epicardium to a region of the myocardium and in an amount effective to increase contractility. At least one of the backing layer or the drug release layer includes a tissue coupling portion for affixing the epicardial patch to an area of the epicardial surface. The epicardial patch is dimensioned and compliant to substantially avoid impeding myocardial functionality when affixed to the area of the epicardial surface. | 03-04-2010 |
20100292670 | DEVICE FOR ADMINISTERING CELLS AND CELL-THERAPY METHODS USING SAID DEVICE - The present invention relates to a device ( | 11-18-2010 |
20110118696 | Device, system, and method for targeted delivery of anti-inflammatory medicaments to a mammalian subject - A device, a system, or a method is described for treating a disease or condition of one or more joints of articulating bone in a mammalian subject. A device is described which includes one or more substrates configured to contact one or more body contours at one or more joints of articulating bone of a mammalian subject; and an applicator supported by the one or more substrates and configured to inject one or more medicaments to one or more joint tissues of the mammalian subject. | 05-19-2011 |
20110118697 | Device, system, and method for targeted delivery of anti-inflammatory medicaments to a mammalian subject - A device, a system, or a method is described for treating a disease or a condition of one or more joints of articulating bone in a mammalian subject. The device provides one or more medicaments to one or more joints of the mammalian subject. A device is described that includes one or more substrates configured to contact one or more body contours in proximity to one or more joints of articulating bone of a mammalian subject; one or more sensors configured to detect one or more physiological conditions of the one or more joints; and one or more microjet applicators supported by the one or more substrates and configured to respond to the one or more sensors by injecting one or more medicaments to the one or more joint tissues of the mammalian subject. | 05-19-2011 |
20150073381 | Encapsulated Cell Therapy Cartridge - The invention provides multi-chamber encapsulated cell therapy cartridge devices that are capable of delivering biologically active molecules as well as methods of using these devices. | 03-12-2015 |
20150314118 | SYSTEM, APPARATUS AND METHOD FOR ESTABLISHING INTRAOSSEOUS VASCULAR ACCESS - System, Apparatus and Method provide intraosseous access to the systemic venous system of a subject. The system includes a bone access device with a drug discharge aperture for implantation, a port including a needle-penetrable septum for subcutaneous placement and a fluid flow path connecting the port and access device. | 11-05-2015 |
20150352347 | METHOD AND APPARATUS FOR FLUID DELIVERY - A method for delivering fluid to a brain of a subject is disclosed. This method includes the steps of: making one or more incisions in a subject; implanting one or more catheters in the brain of the subject; subcutaneously implanting a first part of a modular fluid delivery apparatus in the subject, the first part of the modular fluid delivery apparatus comprising a first length of tubing having a first end and a second end, the first end having a first fluid connector portion attached thereto and the second end being connected to the one or more catheters; and closing the one or more incisions such that the first part of the modular fluid delivery apparatus and the one or more catheters are entirely subcutaneously implanted within the subject. | 12-10-2015 |
20150374830 | MEDICAL DEVICES AND METHODS COMPRISING AN ADHESIVE SHEET CONTAINING A DRUG DEPOT - Improved medical devices and methods are provided that are implantable at or near a target tissue site beneath the skin of a patient, the medical device comprises an adhesive sheet having a region configured to receive a drug depot, the drug depot disposed within the region of the adhesive sheet and the drug depot having at least one surface configured to release a therapeutically effective amount of the drug over a period of at least one day, wherein the adhesive sheet limits movement of the medical device at or near the target tissue site. In some embodiments, the medical device provided can include an effective amount of at least one analgesic and/or at least one anti-inflammatory agent at or near a target site, and can reduce, prevent or treat inflammation and/or pain, particularly postoperative pain or orthopedic degenerative pathology pain. | 12-31-2015 |
20160117481 | SUBCUTANEOUS OUTPATIENT MANAGEMENT - A method of administering insulin includes receiving subcutaneous information for a patient at a computing device and executing a subcutaneous outpatient program for determining recommended insulin dosages. The subcutaneous outpatient program includes obtaining blood glucose data of the patient from a glucometer in communication with the computing device, aggregating blood glucose measurements to determine a representative aggregate blood glucose measurement associated with at least one scheduled blood glucose time interval, and determining a next recommended insulin dosage for the patient based on the representative aggregate blood glucose measurement and the subcutaneous information. The method also includes transmitting the next recommended insulin dosage to a portable device associated with the patient. The portable device displays the next recommended insulin dosage. | 04-28-2016 |
20160158059 | MEMS DEVICE AND METHOD FOR DELIVERY OF THERAPEUTIC AGENTS - Embodiments of an implantable device for delivering a therapeutic agent to a patient include a reservoir configured to contain a liquid comprising the therapeutic agent, and a cannula in fluid communication with the reservoir. The cannula is shaped to facilitate insertion thereof into a patient's eyeball. | 06-09-2016 |